. .

Devices

The diversity of Austrian device innovators

Medical devices and related technologies have always been a strong part of the life science industries in Austria. The Austrian Centre for Medical Innovation and Technology (ACMIT) commenced operations as a Comet K1 competence centre in April 2010 and is active in fundamental and application-oriented research in the field of medical technology. As a K1 centre, the consortium will involve more than 40 national and international partners from science and industry to plan and carry out its collaborative research projects. Research at the centre includes minimally invasive procedures, medical robotics for needle-based interventions and restraint, integrated sensor technology and workflow, interfaces and simulations.

Contents

  1. Surgical instruments
  2. Dialysis
  3. Robotics
  4. Cardiology

Surgical instruments


Since it was set up 150 years ago, Carl Reiner has dedicated itself to the construction and development of state-of-the-art surgical instruments and equipment. Carl Reiner recently took the plunge into the global market with the first microprocessor-controlled unit for jet ventilation. The special feature of this innovative procedure is that it enables patients to be ventilated without a separate air tube.

The proprietary System of Jeder offers a minimally invasive way to do a sinus lift. The conventional procedure for a sinus lift is very invasive and subjects the patient to great stress as a result of substantial swelling, discolouration, and possibly pain. With the Jeder®-System however, it is possible to perform a sinus lift in a minimally invasive way by using high hydraulic pressure.

Dialysis


Fresenius Medical Care Adsorber Tec (former Biotec Systems Krems) was founded as spin-off from Danube University Krems in 1999. After acquisition by Fresenius Medical Care, the site was upgraded to a competence centre for manufacturing and development of adsorbents in the field of medical devices serving products for the treatment of liver failure, autoimmune disorders and severe hypercholesterolemia. The company has a special expertise in the development and production of adsorbents for extracorporeal blood purification.

The Vienna-based Zytoprotec‘s most advanced drug candidate PD-protec™ has completed Phase I/II of clinical development to improve the survival of patients undergoing peritoneal dialysis (PD), an effective treatment option for patients suffering from end-stage renal disease or kidney failure. PD-protec™ is designed to protect peritoneal cells from the degeneration caused by current PD fluids.

Robotics


tyromotion has become one of the world’s leading suppliers of robotics-supported rehabilitation devices sector. has developed the Amadeo® finger rehabilitation system, the Pablo® System hand-arm-shoulder rehabilitation system and the Timo® therapy plate. They guarantee targeted, holistic and successful training of upper extremities and the whole body.

The independent and highly-specialised medical device manufacturer iSYS Medizintechnik develops innovative robotic solutions for micro-invasive interventions in interventional radiology and interventional oncology. iSYS 1, is the most advanced needle guidance platform for interventional procedures due to its compact design and high efficiency, thereby ensuring safety for both, physician and patient.

Cardiology


AFreeze uses cryotechnology for the treatment of cardiac arrhythmia. The company’s technology is a device that shock-freezes tissue in the left atrium via a catheter, thereby eliminating all three possible mechanisms of arterial fibrillation.

EMCOOLS Medical Cooling Systems develops and markets novel non-invasive cooling devices to benefit neurologic outcomes after ischaemic events such as myocardial infarction, stroke and cardiac arrest. In pre-hospital and in-hospital settings, EMCOOLS products deliver a perfect synergy of ease of use and best-in-class product performance.

Miracor Medical Systems is commercialising a new technology for improving outcomes for heart attack patients. Using an approach called Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO), the method seeks to improve blood flow in the heart tissue and improve overall heart function after a severe heart attack.

    NO ACTIVE WIDGETS